Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- 19 December 2016
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 68 (25), 2761-2772
- https://doi.org/10.1016/j.jacc.2016.10.033
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaJournal of the American College of Cardiology, 2016
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPANature Communications, 2016
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 studyThe Lancet, 2015
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery diseaseNature Genetics, 2015
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder PopulationPLoS Genetics, 2014
- Discovery and refinement of loci associated with lipid levelsNature Genetics, 2013
- Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular DiseaseJournal of the American College of Cardiology, 2012
- Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African AncestryCirculation: Cardiovascular Genetics, 2010
- Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density SubfractionsCirculation, 2001
- Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992